INTESTINAL PERFUSION WITH MESENTERIC BLOOD SAMPLING IN WILD-TYPE AND KNOCKOUT MICE
Authors:
- Joachim BrouwersJBJoachim Brouwers
- Alfred H. SchinkelASAlfred H. Schinkel
- Pieter AnnaertPAPieter Annaert
- Patrick AugustijnsPAPatrick Augustijns
- 1 June 2009
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 37 (6) , 1334-1337
Abstract
In the present study, we successfully downscaled, for the first time, the in situ intestinal perfusion technique with mesenteric blood sampling from rat to mouse. To evaluate the feasibility of this approach, we assessed the apparent permeability (Papp) of mouse intestine for a set of marker compounds [atenolol, paracellular transport; metoprolol, transcellular transport; talinolol, P-glycoprotein (P-gp)-mediated efflux] in both wild-type and P-gp-deficient mice. In wild-type mice, the observed Papp values for atenolol (1.8 ± 0.3 × 10–6 cm/s) and metoprolol (50.2 ± 20.1 × 10–6 cm/s) were not significantly affected by inclusion of the P-gp inhibitor verapamil. In contrast, the Papp value for talinolol (0.9 ± 0.3 × 10–6 cm/s) increased 5-fold in the presence of verapamil. The similarity between these values and previously determined Papp values in rats indicates comparable passive barrier functions and P-gp-mediated efflux transport between mice and rats. In comparison with wild-type mice, the apparent permeability in P-gp-deficient mdr1a/1b(–/–) mice was significantly altered for talinolol (7-fold increase) but not for atenolol or metoprolol. Because of the availability of knockout mice, the intestinal perfusion technique with mesenteric blood sampling in mice may become an important tool to elucidate the role of intestinal metabolism and active transport in drug absorption during preclinical drug evaluation.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratoriesEuropean Journal of Pharmaceutical Sciences, 2008
- Targeted Disruption of Peptide TransporterPept1Gene in Mice Significantly Reduces Dipeptide Absorption in IntestineMolecular Pharmaceutics, 2008
- Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorptionAdvanced Drug Delivery Reviews, 2008
- Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal LumenMolecular Pharmacology, 2005
- HPLC with programmed wavelength fluorescence detection for the simultaneous determination of marker compounds of integrity and P-gp functionality in the Caco-2 intestinal absorption modelJournal of Pharmaceutical and Biomedical Analysis, 2004
- Quantitative Evaluation of the Function of Small Intestinal P-Glycoprotein: Comparative Studies Between in Situ and in VitroPharmaceutical Research, 2003
- Apricot Extract Inhibits the P-gp–Mediated Efflux of TalinololJournal of Pharmaceutical Sciences, 2002
- Strategies for Absorption Screening in Drug Discovery and DevelopmentCurrent Topics in Medicinal Chemistry, 2001
- In Vitro, Ex Vivo, and In Situ Intestinal Absorption Characteristics of the Antiviral Ester Prodrug Adefovir DipivoxilJournal of Pharmaceutical Sciences, 2000
- Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral AdministrationClinical Pharmacokinetics, 1999